L-Thyroxine (sodium)

CAT:
804-HY-18341B-01
Size:
500 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
L-Thyroxine (sodium) - image 1

L-Thyroxine (sodium)

  • Description:

    L-Thyroxine sodium (Levothyroxine sodium) is a synthetic hormone for the research of hypothyroidism. DIO enzymes convert biologically active thyroid hormone (Triiodothyronine, T3) from L-Thyroxine (T4) [1].
  • Product Name Alternative:

    Levothyroxine (sodium) ; T4 (sodium)
  • UNSPSC:

    12352005
  • Hazard Statement:

    H361, H372
  • Target:

    Endogenous Metabolite; Thyroid Hormone Receptor
  • Type:

    Reference compound
  • Related Pathways:

    Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
  • Applications:

    Metabolism-protein/nucleotide metabolism
  • Field of Research:

    Endocrinology; Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/l-thyroxine-sodium.html
  • Concentration:

    10mM
  • Purity:

    99.75
  • Solubility:

    0.5 M NaOH : 25 mg/mL (ultrasonic; warming; adjust pH to 11 with NaOH; heat to 60°C) |DMSO : 62.5 mg/mL (ultrasonic) |H2O : 14 mg/mL (ultrasonic; adjust pH to 12 with NaOH)
  • Smiles:

    N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O[Na])=O
  • Molecular Formula:

    C15H10I4NNaO4
  • Molecular Weight:

    798.85
  • Precautions:

    H361, H372
  • References & Citations:

    [1]Arici M, et al. Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients. Endocr J. 2018 Mar 28;65 (3) :317-323.|[2]Corriveau S, et al. Levothyroxine treatment generates an abnormal uterine contractility patterns in an in vitro animalmodel. J Clin Transl Endocrinol. 2015 Sep 9;2 (4) :144-149.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, sealed storage, away from moisture and light)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    Launched
  • Isoform:

    Human Endogenous Metabolite
  • Citation 01:

    J Drug Deliv Sci Technol. 2023 Sep 28, 105008.|Cell Rep Med. 2023 Jun 20;4 (6) :101061.|Dis Model Mech. 2024 Aug 14:dmm.050748.|EMBO J. 2024 Aug;43 (15) :3090-3115.|Mol Brain. 2021 Jan 27;14 (1) :25.|Nat Immunol. 2024 Apr;25 (4) :659-670.|Sci Rep. 2022 Jul 4;12 (1) :11259.|Stem Cell Rev Rep. 2021 Jun;17 (3) :999-1013.
  • CAS Number:

    [55-03-8]